To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Activation of Fms-like ty… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.

Journal article
Authors Sofia E M Andersson
Mattias Svensson
Malin Erlandsson
Mats Dehlin
Karin Andersson
Maria Bokarewa
Published in PloS one
Volume 7
Issue 10
Pages e47668
ISSN 1932-6203
Publication year 2012
Published at Institute of Medicine, Department of Rheumatology and Inflammation Research
Pages e47668
Language en
Links dx.doi.org/10.1371/journal.pone.004...
Keywords Adult, Aged, Aged, 80 and over, Alternative Splicing, drug effects, genetics, Animals, Arthritis, Rheumatoid, enzymology, pathology, Bone Marrow, drug effects, metabolism, Disease Models, Animal, Down-Regulation, drug effects, Enzyme Activation, drug effects, Female, Humans, Inhibitor of Apoptosis Proteins, genetics, metabolism, Male, Membrane Proteins, pharmacology, Mice, Mice, Inbred BALB C, Middle Aged, RNA, Small Interfering, metabolism, Repressor Proteins, genetics, metabolism, Signal Transduction, drug effects, Spleen, drug effects, metabolism, Up-Regulation, drug effects, Young Adult, fms-Like Tyrosine Kinase 3, antagonists & inhibitors, metabolism
Subject categories Immunobiology

Abstract

Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthritis. Studies on 90 RA patients (median age 60.5 years [range, 24-87], disease duration 10.5 years [range, 0-35]) show a strong positive association between the levels of survivin and Flt3L in blood. Here, we present experimental evidence connecting survivin and Flt3L signaling. Treatment of BALB/c mice with Flt3L led to an increase of survivin in the bone marrow and in splenic dendritic cells. Flt3L changed the profile of survivin splice variants, increasing transcription of the short survivin40 in the bone marrow. Treatment with an Flt3 inhibitor reduced total survivin expression in bone marrow and in the dendritic cell population in spleen. Inhibition of survivin transcription in mice, by shRNA lentiviral constructs, reduced the gene expression of Flt3L. We conclude that expression of survivin is a downstream event of Flt3 signaling, which serves as an essential mechanism supporting survival of leukocytes during their differentiation, and maturation of dendritic cells, in RA.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?